Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
121-135 of 422
Adherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Clinician's RoundtableAdherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Mallik Greene, PhD
Initiating Colorectal Cancer Screening Earlier: A Look at the Evidence
Clinician's RoundtableInitiating Colorectal Cancer Screening Earlier: A Look at the Evidence
Theodore Levin, MD
Streamlining Colorectal Cancer Screening in OB/GYN Care
Clinician's RoundtableStreamlining Colorectal Cancer Screening in OB/GYN Care
Jemel Bingham, MD
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Project Oncology®ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Charles Turck, PharmD, BCPS, BCCCP
Guru P. Sonpavde, MD
Preventing Colorectal Cancer with Smart Screening
Clinician's RoundtablePreventing Colorectal Cancer with Smart Screening
Harish Gagneja, MD
The Importance of Colon Cancer Screening for Baby Boomers
Everyday Family MedicineThe Importance of Colon Cancer Screening for Baby Boomers
Jennifer Caudle, DO, FACOFP
- advertisement
Disaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
Clinician's RoundtableDisaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
Charles Turck, PharmD, BCPS, BCCCP
Gloria Coronado, PhD
Colorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Clinician's RoundtableColorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Brian P. McDonough, MD, FAAFP
Carolyn Rutter, PhD
Gloria Coronado, PhD
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Clinician's RoundtableCost Considerations for Colorectal Cancer Screening: Examining the Data
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Clinician's RoundtableWeighing the Environmental Impact of Colorectal Cancer Screening Methods
Peter Buch, MD, FACG, AGAF, FACP
A. Mark Fendrick, MD
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Clinician's RoundtableEmbedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
Clinician's RoundtableUsing FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
Ashley Baker, MSN, PMHNP
Heather Allen, PhD
Ran Li, PhD
- advertisement
Redefining First-Line Therapy in mCSPC: Applying Evidence in Practice
Project Oncology®Redefining First-Line Therapy in mCSPC: Applying Evidence in Practice
Brian P. McDonough, MD, FAAFP
William Oh, MD
Integrating Guideline Updates in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®Integrating Guideline Updates in Squamous Cell Carcinoma of the Anal Canal
Charles Turck, PharmD, BCPS, BCCCP
Stacey Cohen, MD
